MedPath

The Effect of Initiating Intravenous Oxytocin Infusion before Uterine Incision on Blood Loss During Elective Caesarean Section: A Randomized Clinical Trial

Not Applicable
Completed
Conditions
Post partum haemorrhage prevention
Registration Number
PACTR202111830813291
Lead Sponsor
wigboji Ndukwe Wilson
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
180
Inclusion Criteria

•Singleton pregnancy
•Term pregnancy (37 - 42 weeks gestational age)
•Booked for elective caesarean section,
•Willingness to participate in the study, were included.

Exclusion Criteria

•Women with multiple gestation
•Women with polyhydramnios or macrosomia
•Parturients with antepartum haemorrhage
•Parturients with heart or renal disease
•Women with 2 or more previous CS
•Women with bleeding disorders
•Women with previous history of postpartum haemorrhage
•Women who did not consent to the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.